{
  "ptid_time": "127_S_6241_2020-08-25",
  "img_path": "/data/qiuhui/data/adni/images/127_S_6241/2020-08-25/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 64,837 mm³, 131.0% above the reference mean. With a Z-score of 3.00 (99.9th percentile), this represents significant enlargement; hippocampal volume measures 5,363 mm³, 24.6% below the reference mean. With a Z-score of -2.26 (1.2th percentile), this represents significant atrophy; whole brain volume measures 928,785 mm³, 4.7% below the reference mean. With a Z-score of -0.59 (27.7th percentile), this represents normal volume ; entorhinal cortex volume measures 3,122 mm³, 15.0% below the reference mean. With a Z-score of -0.92 (17.9th percentile), this represents normal volume ; fusiform gyrus volume measures 16,823 mm³, 1.1% below the reference mean. With a Z-score of -0.10 (46.0th percentile), this represents normal volume ; middle temporal gyrus volume measures 20,062 mm³, 4.7% above the reference mean. With a Z-score of 0.40 (65.7th percentile), this represents normal volume . ",
  "text_data": "Age is 74.2 years. Gender is Female. Education: 18 years. MMSE: 29.0. MoCA: 21.0. Logical Memory: 2.0. APOEε4 alleles: 0.0. Biomarker levels: Flobetaben (FBB): 1.50 SUVR (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant hippocampal atrophy (Z-score -2.26) and marked ventricular enlargement (Z-score 3.00), both of which are strong neuroimaging biomarkers for Alzheimer's disease. Despite a normal MMSE (29/30), the MoCA score (21/30) suggests mild cognitive impairment, particularly in executive function and memory domains. The absence of APOE4 does not rule out AD, as hippocampal atrophy is a key feature.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**, likely due to Alzheimer’s pathology.  \n\n**Confidence:** **High** (due to clear hippocampal atrophy, ventricular enlargement, and MoCA <26 despite normal MMSE).",
  "timestamp": "2025-07-26T13:31:09.171642"
}